[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352167-105":59,"doc-detail-352167-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","radiomics-based-mri-model-for-differentiating-ovarian-cystadenoma-and-cystadenocarcinoma","Radiomics-based MRI model for differentiating ovarian cystadenoma and cystadenocarcinoma","","Radiomics-based MRI modeling is developed to accurately distinguish benign from malignant epithelial ovarian tumors and support timely intervention for high-risk patients while reducing unnecessary overtreatment. Using a retrospective cohort, the approach extracts 2286 radiomics features from manually segmented T2-weighted MRI lesions and applies dimensionality reduction before training machine-learning classifiers. A combined model incorporating serum biomarkers CA-125 and HE-4 is evaluated with statistical comparisons (DeLong and McNemar). Results show strong discrimination, with quantile logistic regression achieving an AUC of 0.92.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/radiomics-based-mri-model-for-differentiating-ovarian-cystadenoma-and-cystadenocarcinoma/352167/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/radiomics-based-mri-model-for-differentiating-ovarian-cystadenoma-and-cystadenocarcinoma/352167.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the objective of the radiomics-based MRI study?","Question",{"text":113,"@type":114},"To develop a radiomics-based machine learning model that differentiates noncancerous ovarian lesions from cancerous lesions, focusing on ovarian cystadenoma versus cystadenocarcinoma.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were radiomics features and models constructed?",{"text":118,"@type":114},"T2-weighted MRI lesions were manually segmented and 2286 radiomics features were extracted. After dimensionality reduction, features were used to train machine-learning models with different data scaling methods and classifiers, including logistic regression and partial least squares discriminant analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"Did adding serum biomarkers improve performance?",{"text":122,"@type":114},"Yes. The inclusion of serum biomarkers CA-125 and HE-4 significantly improved the model’s performance compared with radiomics-only modeling.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352167,1790213126,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 27 August 2026  \nDOI 10.3389/fonc.2026.1839964  \nOPEN ACCESS  \nEDITED BY  \nAyse Ayhan,  \nJohns Hopkins University, United States  \nREVIEWED BY  \nAlireza Eftekhari Moghadam, Baqiyatallah University of Medical Sciences, Iran  \nWasay Nizam,  \nAllegheny Health Network, United States  \n*CORRESPONDENCE  \nJun Chen  \n[whuchenjun@163.com](whuchenjun@163.com)  \nRECEIVED 26 March 2026  \nREVISED 23 July 2026  \nACCEPTED 24 July 2026  \nPUBLISHED 27 August 2026  \nCITATION  \nRamjaun MM, Shrestha P, Bhoodoo BKH, Dai L, Abdrakhimov B, Huang Z, Wang X, Shrestha P and Chen J (2026)  \nRadiomics-based MRI model for differentiating ovarian cystadenoma and cystadenocarcinoma.  \nFront. Oncol. 16:1839964 .  \ndoi: 10.3389/fonc.2026.1839964  \nCOPYRIGHT  \n© 2026 Ramjaun, Shrestha, Bhoodoo, Dai, Abdrakhimov, Huang, Wang, Shrestha and Chen. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRadiomics-based MRI model for differentiating ovarian cystadenoma and cystadenocarcinoma  \nMohamed Muntasir Ramjaun 1, Palpasa Shrestha 1, Beebee Kaneeze Hasanayn Bhoodoo 2, Lisong Dai 1, Bulat Abdrakhimov 3, Zhen Huang 4, Xuechun Wang4, Prajal Shrestha 5 and Jun Chen 1*  \n1 Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China, 2 Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 3 Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China, 4 Department of Research and Development, United Imaging Intelligence, Shanghai, China, 5School of Built Environment, Engineering and Computing, Leeds Beckett University, Leeds, United Kingdom  \nBackground: Accurate differentiation between benign and malignant ovarian tumors is crucial to ensure timely intervention for high-risk patients and minimizing overtreatment in others. Thus, the objective was to develop aradiomics-based machine learning model to differentiate between noncancerous and cancerous lesions in ovaries.  \nMethods: This retrospective study included 271 patients with ovarian cystade nocarcinoma and 266 patients with ovarian cystadenoma who underwent T2-weighted magnetic resonance imaging (MRI) . Lesions were manually segmented, and 2286 radiomics features were extracted. Following dimensionality reduction, features were used to train machine learning models with different combinations of data scaling (min-max, Z-score, and quantile transformations) and classiﬁers (logistic regression and partial least squares discriminant analysis) . In addition, a model combining radiomics features and cancer biomarker data (CA-125 and HE-4) was developed. Models were compared using the DeLong’s test and McNemar ’s tests.  \nResults: A total of 37 features were used for model development. The quantile logistic regression model exhibited the highest performance, achieving an AUC of 0.92, a sensitivity of 0.87, and a speciﬁcity of 0.83, which was signiﬁcantly higher compared to all models except for Z-score logistic regression model. The inclusion of serum biomarkers (CA-125 and HE-4) signiﬁcantly improved the performance of the model.  \nConclusion: T2-weighted MRI radiomics-based models accurately differentiated between benign and malignant epithelial ovarian tumors.  \nKEYWORDS  \nmachine learning, magnetic resonance imaging, ovarian cystadenocarcinoma, ovarian cystadenoma, radiomics  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nGlobally, over 300,000 women are diagnosed with ovarian cancer annually. Ovarian cancer continues to carry the highest mortality rate among all gynecolo","cbCaibjhhn1A3l2I","https://ap.wps.com/l/cbCaibjhhn1A3l2I","pdf",1637105,"English","# Background\n## Clinical need for differentiating ovarian tumors\n# Methods\n## Retrospective cohort and MRI acquisition\n## Radiomics feature extraction and modeling\n## Biomarker integration and model comparison\n# Results\n## Selected features and classification performance\n## Impact of adding CA-125 and HE-4\n# Conclusion\n## Diagnostic value of T2-weighted MRI radiomics","[{\"question\":\"What was the objective of the radiomics-based MRI study?\",\"answer\":\"To develop a radiomics-based machine learning model that differentiates noncancerous ovarian lesions from cancerous lesions, focusing on ovarian cystadenoma versus cystadenocarcinoma.\"},{\"question\":\"How were radiomics features and models constructed?\",\"answer\":\"T2-weighted MRI lesions were manually segmented and 2286 radiomics features were extracted. After dimensionality reduction, features were used to train machine-learning models with different data scaling methods and classifiers, including logistic regression and partial least squares discriminant analysis.\"},{\"question\":\"Did adding serum biomarkers improve performance?\",\"answer\":\"Yes. The inclusion of serum biomarkers CA-125 and HE-4 significantly improved the model’s performance compared with radiomics-only modeling.\"}]","Radiomics-based MRI model for differentiating ovarian cystadenoma and cystadenocarcinoma | PDF",1790098040,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05fd6e351878325071457272b7ad64cc.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43826bc293ac0f1a81baefa4ac3f23c0.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dc802c9a8f94a685956343c08905a09.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44f29272220f2c44af72bd74df28c271.webp",980,1385]